Pandemic influenza A(H1N1)pdm09 improves vaccination routine in subsequent years: A cohort study from 2009 to 2011

Vaccine

Volumn 31, Issue 6, 2013, Pages 900-905

  Tacken, Margot A J B ^a   Jansen, Birgit ^a   Mulder, Jan ^a   Visscher, Stefan ^b   Heijnen, Marie Louise A ^c   Campbell, Stephen M ^d   Braspenning, Jozé C C ^a,d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Influenza; Pandemics; Prevention; Vaccination

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GENERAL PRACTICE; HUMAN; INFECTION RISK; INFLUENZA VACCINATION; INFORMATION PROCESSING; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEASONAL INFLUENZA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NETHERLANDS; PATIENT ACCEPTANCE OF HEALTH CARE; VACCINATION; YOUNG ADULT;

EID: 84872616656     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.12.002     Document Type: Article

References (44)

1. MIV The macro-epidemiology of influenza vaccination in 56 countries, 1997-2003. Vaccine 2005, 23(October (44)):5133-5143.
2. Mereckiene J., Cotter S., Nicoll A., Levy-Bruhl D., Ferro A., Tridente G., et al. National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill 2008, 13(October (43)).
3. Blank P.R., Szucs T.D. Increasing influenza vaccination coverage in recommended population groups in Europe. Expert Rev Vaccines 2009, 8(April (4)):425-433.
4. Blank P.R., Schwenkglenks M., Szucs T.D. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect 2009, 58(June (6)):446-458.
5. Blank P.R., Schwenkglenks M., Szucs T.D. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 2008, 8:272.
6. Kroneman M.W., van Essen G.A., Tacken M.A., Paget W.J., Verheij R. Does a population survey provide reliable influenza vaccine uptake rates among high-risk groups? A case-study of The Netherlands. Vaccine 2004, 22(June (17-18)):2163-2170.
7. Fiore AF, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP); 2010. 2010 20100806 DCOM-20100817(1545-8601 (Electronic)).
8. Setse RF, Euler GL, Gonzalez-Feliciano AG, Bryan LN, Furlow C, Weinbaum CM, et al. Influenza vaccination coverage - United States, 2000-2010; 2011. 20110324 DCOM-20110404(1545-8636 (Electronic)).
9. Gezondheidsraad Griepvaccinatie: herziening van de indicatiestelling 2007, The Health Council of the Netherlands (Gezondheidsraad), Den Haag.
10. Loerbroks A., Stock C., Bosch J.A., Litaker D.G., Apfelbacher C.J. Influenza vaccination coverage among high-risk groups in 11 European countries. Eur J Public Health 2011, July.
11. Kroneman M., Paget W.J., van Essen G.A. Influenza vaccination in Europe: an inventory of strategies to reach target populations and optimise vaccination uptake. Euro Surveill 2003, 8(June (6)):130-138.
12. Palache A. Seasonal influenza vaccine provision in 157 countries (2004-2009) and the potential influence of national public health policies. Vaccine 2011, 29(51):9459-9466.
13. Bekker H.L., Gough D., Williams M. Attendance choices about the Influenza Immunization Programme: EVIDENCE for targeting patients' beliefs. Psychol Health Med 2003, 8(August (3)):279-288.
14. Yarwood J. Communicating vaccine benefit and risk - lessons from the medical field. Vet Microbiol 2006, 117(October (1)):71-74.
15. Bish A., Yardley L., Nicoll A., Michie S. Factors associated with uptake of vaccination against pandemic influenza: a systematic review. Vaccine 2011, 29(September (38)):6472-6484.
16. WHO World now at the start of 2009 influenza pandemic. Statement to the press by WHO Director-General Dr. Margaret Chan 2009, Available at:. http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/
17. WHO Safety of pandemic vaccines. Pandemic (H1N1) 2009 briefing note 16 2009, Available from:. http://www.who.int/csr/disease/swineflu/notes/briefing_20091119/en/index.html.
18. Gezondheidsraad Vaccinatie tegen pandemische influenza A/H1N1 2009: doelgroepen en prioritering 2009, The Health Council of the Netherlands (Gezondheidsraad), Den Haag.
19. Tsiodras S., Sypsa V., Hatzakis A. The vaccination campaign against 2009 pandemic influenza A(H1N1) and its continued importance in view of the uncertainty surrounding the risk associated with the pandemic. Euro Surveill 2010, 15(January (3)).
20. Bijl D., Schellekens H. The sponsored pandemic of the Mexican flu?. Int J Risk Saf Med 2011, 23(2):73-79.
21. Hilton S., Hunt K. UK newspapers' representations of the 2009-10 outbreak of swine flu: one health scare not over-hyped by the media?. J Epidemiol Community Health 2011, 65(October (10)):941-946.
22. Salathe M., Khandelwal S. Assessing vaccination sentiments with online social media: implications for infectious disease dynamics and control. PLoS Comput Biol 2011, 7(October (10)):e1002199.
23. van Rijswoud E. Virology experts in the boundary zone between science, policy and the public: a biographical analysis. Minerva 2010, 48(June (2)):145-167.
24. Trivellin V., Gandini V., Nespoli L. Low adherence to influenza vaccination campaigns: is the H1N1 virus pandemic to be blamed?. Ital J Pediatr 2011, 37:54.
25. De Vries H., Dijkstra M., Kuhlman P. Self-efficacy: the third factor besides attitude and subjective norm as a predictor of behavioural intentions. Health Educ Res 1988, 3(September (3)):273-282.
26. De Vries H., Backbier E., Kok G., Dijkstra M. The impact of social influences in the context of attitude, self-efficacy, intention and previous behaviors as predictors of smoking onset. J Appl Soc Psychol 1995, 25:237-257.
27. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991, 50(2):179-211.
28. Fishbein M., Ajzen I. Belief, attitude, intention and behavior: an introduction to theory and research 1975, Reading, MA, Addison-Wesley.
29. Bandura A. Social foundations of thought and action: a social cognitive theory 1976, Prentice-Hall, Englewood Cliffs, NJ.
30. Hyde T.B., Dentz H., Wang S.A., Burchett H.E., Mounier-Jack S., Mantel C.F. The impact of new vaccine introduction on immunization and health systems: a review of the published literature. Vaccine 2012, 30(45):6347-6358.
31. Stirbu-Wagner I.D.S., Visscher S., Davids R., Gravestein J.V., Abrahamse H., Van Althuis T., Jansen B., Schlief A., Tiersma W., Walk C., Wentink E., Wennekes L., Braspenning J., Korevaar J.C. Landelijke Informatienetwerk Huisartsenzorg. Feiten en cijfers over de huisartsenzorg in Nederland 2010, Available from:. http://www.linh.nl/.
32. Tacken M.A., Braspenning J.C., Berende A., Hak E., de Bakker D.H., Groenewegen P.P., et al. Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data. Vaccine 2004, 22(August (23-24)):2985-2992.
33. Tacken M., Braspenning J., Spreeuwenberg P., van den Hoogen H., van Essen G., de Bakker D., et al. Patient characteristics determine differences in the influenza vaccination rate more so than practice features. Prev Med 2002, 35(October (4)):401-406.
34. Lamberts H., Wood M. ICPC. International Classification of Primary Care 1987, Oxford University Press, Oxford.
35. van Essen G.A., Bueving H.J., Voordouw A.C.G., Berg H.F., van der Laan J.R., Van Lidt de Jeude C.P., et al. NHG-standaard Influenza en influenzavaccinatie Available at:. http://nhg.artsennet.nl/kenniscentrum/k_richtlijnen/k_nhgstandaarden/Samenvattingskaartje-NHGStandaard/M35_svk.htm.
36. Opstelten W., van Essen G.A., van der Laan J.R., Geijer R.M., Goudswaard A.N. [Summary of the practice guideline 'Influenza and influenza vaccination' (first revision) from the Dutch College of General Practitioners]. Ned Tijdschr Geneeskd 2008, 152(September (39)):2116-2119.
37. Leyland A.H., Groenewegen P.P. Multilevel modelling and public health policy. Scand J Public Health 2003, 31(4):267-274.
38. Snijders T.A.B., Bosker R.J. Multilevel analysis an introduction to basic and advanced multilevel modeling 1999, SAGE publications, London.
39. Eastwood K., Durrheim D.N., Jones A., Butler M. Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public. Med J Aust 2010, 192(January (1)):33-36.
40. Maurer J., Harris K.M., Parker A., Lurie N. Does receipt of seasonal influenza vaccine predict intention to receive novel H1N1 vaccine: evidence from a nationally representative survey of U.S. adults. Vaccine 2009, 27(September (42)):5732-5734.
41. Guthmann J.-P., Fonteneau L., Bonmarin I., Lévy-Bruhl D. Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011. Vaccine 2012, 30(6):995-997.
42. SNPG. All delivered and billed influenza vaccines in the Netherlands for the vaccination year 2010-2011 (Stichting Nationaal Programma Grieppreventie/National Program Influenza Prevention Foundation) (unpublished list 30-3-2011).
43. Schellevis F., Jabaaij L. Continuïteit en verhuizende patiënten. Huisarts en Wetenschap 2006, 49(2):104.
44. Tacken M., Mulder M., Visscher S., Tiersma W., Donkers J., Verheij R., et al. Monitoring vaccinatiegraad nationaal Programma Grieppreventie 2009 2010, LINH/IQ Healthcare, Nijmegen.